Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Psychemedics (PMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2004	12-2003	12-2002	12-2001	12-2000
Cash Flows From Operating Activities
Net Income	2,764	1,218	1,250	230	1,690
Depreciation Amortization	534	872	1,140	1,260	1,270
Income taxes - deferred	-11	-196	N/A	N/A	N/A
Accounts receivable	-1,140	-426	N/A	N/A	N/A
Accounts payable and accrued liabilities	156	61	N/A	N/A	N/A
Other Working Capital	-1,018	179	-4	1,120	390
Other Operating Activity	984	366	44	-150	-150
Operating Cash Flow	$2,269	$2,073	$2,430	$2,460	$3,200

Cash Flows From Investing Activities
PPE Investments	-377	-262	-200	-580	-770
Purchase Of Investment	-13	14	N/A	N/A	N/A
Other Investing Activity	0	0	-10	-10	4,900
Investing Cash Flow	$-391	$-248	$-210	$-590	$4,130

Cash Flows From Financing Activities
Common Stock Repurchased	N/A	-1,178	N/A	N/A	N/A
Dividend Paid	-1,641	-1,660	-1,260	-2,110	-3,390
Other Financing Activity	0	387	-420	-80	-1,410
Financing Cash Flow	$-1,641	$-2,451	$-1,680	$-2,190	$-4,800

Beginning Cash Position	3,023	3,649	3,110	3,430	890
End Cash Position	3,260	3,023	3,640	3,110	3,430
Net Cash Flow	$238	$-626	$530	$-320	$2,530

Free Cash Flow
Operating Cash Flow	2,269	2,073	2,430	2,460	3,200
Capital Expenditure	-377	-262	N/A	N/A	N/A
Free Cash Flow	1,892	1,811	2,430	2,460	3,200